Evaluating the risk of releasing genetically engineered organisms

Lone Simonsen*, Bruce R. Levin

*Corresponding author

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

This article considers the question of a priori assessment of the safety of releasing recombinant DNA engineered organisms. Now and for the foreseeable future, decisions to release such an organism must be based on the results of limited, case-by-case risk assessment studies. The criteria calling for the termination of release programs must be agreed upon in advance of these studies. There is no justification for excluding classes of release organisms from risk assessment. Theory is useful in suggesting a hierarchy of risks, raising the questions that have to be addressed in case-by-case risk assessment and providing protocols for the standardization and execution of these studies. We do not believe that theory can be used to argue categorically for or against the safety of specific releases of recombinant DNA engineered organisms.

OriginalsprogEngelsk
TidsskriftTrends in Biotechnology
Vol/bind6
Udgave nummer4
Sider (fra-til)S27-S30
ISSN0167-7799
DOI
StatusUdgivet - apr. 1988
Udgivet eksterntJa

Citer dette